ConductScience.org, home

Paper34278663

Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.

Kowada A and 1 other. Helicobacter, 2021. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis. Papers, record 34278663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34278663

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
PubMed
Journal
Helicobacter
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.92
iCite
Revised in PubMed
2022-07-31
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kowada AAkikohttps://orcid.org/0000-0001-5200-4300
2Asaka MMasahiro

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Helicobacter InfectionsMajor topic
Helicobacter pyloriMajor topic
Stomach NeoplasmsMajor topic
Aged
Cost-Benefit Analysis
Humans
Japan
Middle Aged
Policy

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No funding was received for this study.PubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127342689Japanese gastric cancer treatment guidelines 2014 (ver. 4).Gastric Cancer2017https://conductscience.org/library/papers/27342689PubMed
231111585Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.Helicobacter2019https://conductscience.org/library/papers/31111585PubMed
333004546Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.Gut2020https://conductscience.org/library/papers/33004546PubMed
431559966Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.Lancet Infect Dis2019https://conductscience.org/library/papers/31559966PubMed
533519193Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer.Patient Prefer Adherence2021https://conductscience.org/library/papers/33519193PubMed
624833876Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.World J Gastroenterol2014https://conductscience.org/library/papers/24833876PubMed
731320930Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients.Ther Adv Gastroenterol2019https://conductscience.org/library/papers/31320930PubMed
825162885Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.N Engl J Med2014https://conductscience.org/library/papers/25162885PubMed
931190581Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries.Scand J Gastroenterol2019https://conductscience.org/library/papers/31190581PubMed
1032523315Clinicopathological features of early gastric cancers arising in Helicobacter pylori uninfected patients.World J Gastroenterol2020https://conductscience.org/library/papers/32523315PubMed
1131673902Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.Dig Dis Sci2020https://conductscience.org/library/papers/31673902PubMed
1232285569
Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.
Helicobacter2020https://conductscience.org/library/papers/32285569PubMed
1326198377Helicobacter pylori eradication for the prevention of gastric neoplasia.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26198377PubMed
1424162382Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan.J Gastroenterol2014https://conductscience.org/library/papers/24162382PubMed
1531857433Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer.Gut2020https://conductscience.org/library/papers/31857433PubMed
1628771894Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.Helicobacter2017https://conductscience.org/library/papers/28771894PubMed
1732792335Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands.Gut2021https://conductscience.org/library/papers/32792335PubMed
1829872276Estimation of population-based utility weights for gastric cancer-related health states.Patient Prefer Adherence2018https://conductscience.org/library/papers/29872276PubMed
1924914352Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis.World J Gastroenterol2014https://conductscience.org/library/papers/24914352PubMed
2027623463Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.JAMA2016https://conductscience.org/library/papers/27623463PubMed

See all 38 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42283782Helicobacter pylori eradication in the face of escalating anti-microbial resistance: Geographic heterogeneity and emerging treatment strategies.Indian J Gastroenterol2026https://conductscience.org/library/papers/42283782PubMed
42178557Early population-level impact of Helicobacter pylori eradication on gastric cancer mortality in Japan: a counterfactual analysis of short-term divergence.Popul Health Metr2026https://conductscience.org/library/papers/42178557PubMed
41830305Usefulness of Molecular Diagnostic Kits for Detecting Helicobacter pylori Infection in Patients Receiving Proton Pump Inhibitors and Potassium-Competitive Acid Blockers.Biomed Res Int2026https://conductscience.org/library/papers/41830305PubMed
40550534Experts' Perceptions Regarding Testing for Helicobacter pylori Infection During Upper Gastrointestinal Endoscopy and Subsequent Eradication Therapy.Korean J Helicobacter Up Gastrointest Res2025https://conductscience.org/library/papers/40550534PubMed
40433232Current Status of Gastric Cancer Screening and Future Perspectives.DEN Open2026https://conductscience.org/library/papers/40433232PubMed
40131569Economic Evaluation of Gastric Cancer Screening Strategies: A Systematic Review.J Gastrointest Cancer2025https://conductscience.org/library/papers/40131569PubMed
40059928Cost-effectiveness of adding a Helicobacter pylori antibody test to the upper gastrointestinal series in gastric cancer screening at the workplace.Environ Occup Health Pract2023https://conductscience.org/library/papers/40059928PubMed
39735441Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges.J Natl Cancer Cent2024https://conductscience.org/library/papers/39735441PubMed
39684537The Aging Stomach: Clinical Implications of H. pylori Infection in Older Adults-Challenges and Strategies for Improved Management.Int J Mol Sci2024https://conductscience.org/library/papers/39684537PubMed
38204445Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention.Chin J Cancer Res2023https://conductscience.org/library/papers/38204445PubMed
38006568
Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric cancer screening labeled by serum examination in place of aged gastric cancer organized screening systems (GALAPAGOS study).
Gastric Cancer2024https://conductscience.org/library/papers/38006568PubMed
37680407Unpacking the Racial Gap: Helicobacter pylori Infection Clearance Among Different Racial Groups.Cureus2023https://conductscience.org/library/papers/37680407PubMed
36565366A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening.Dig Dis Sci2023https://conductscience.org/library/papers/36565366PubMed
36538198The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis.Clin Exp Med2023https://conductscience.org/library/papers/36538198PubMed
36317116Helicobacter Pylori Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis.Biomed Res Int2022https://conductscience.org/library/papers/36317116PubMed
36204804Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations.Saudi J Gastroenterol2023https://conductscience.org/library/papers/36204804PubMed
35343031Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.Helicobacter2022https://conductscience.org/library/papers/35343031PubMed
35078854What is the general Chinese public's awareness of and attitudes towards Helicobacter pylori screening and associated health behaviours? A cross-sectional study.BMJ Open2022https://conductscience.org/library/papers/35078854PubMed
34660627Helicobacter pylori Infection in Geriatric Patients: Current Situation and Treatment Regimens.Front Med (Lausanne)2021https://conductscience.org/library/papers/34660627PubMed
34278663Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.Helicobacter2021https://conductscience.org/library/papers/34278663PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34278663

GET https://conductscience.org/api/papers/v1/34278663/references?page=2